Close

Please fill all fields and submit the form.

Name:
Email:

Phone:

Notes:



Close

Please fill out all fields in the form. Please be as detailed as possible. We will respond with pricing and availability within 1-2 business days.

Name:
Company/Institution:

Phone:
Email:

Disease:

Organ/Tissue type:

Format:

Number of patients/donors required for the study:

Clinical Specifications:

Applications/Research topic:

EML4-ALK Fusion Gene Detection Kit

EML4-ALK Fusion Gene Detection Kit Description

EML4-ALK Fusion Gene Detection Kit is a sensitive and selective assay for the detection of the twenty-one most common fusion transcripts of the chimeric EML4-ALK gene.

  

The EML4-ALK fusion oncogene represents one of the newest molecular targets in non-small-cell lung cancer (NSCLC). First described in 2007, the fusion results from a small inversion within chromosome 2p. This inversion leads to expression of a chimeric tyrosine kinase having the N-terminal half of echinoderm microtubule-associated protein-like 4 (EML4) fused to the intracellular kinase domain of anaplastic lymphoma kinase (ALK). The EML4-ALK protein possesses potent oncogenic activity both in vitro and in vivo. This activity can be blocked by small-molecule inhibitors, supporting a role for EML4-ALK as a key driver of lung tumorigenesis.

Technological Principles:

The EML4-ALK kit employs proprietary real-time PCR technology to detect the twenty-one most common EML4-ALK fusion transcripts. RNA that has been purified from the FFPE tissue is first reverse transcribed to cDNA with RT enzyme supplied with the kit. The EML4-ALK fusion cDNAs are then specifically amplified with cross-junction PCR primers and quantitatively detected with fluorescent probes.